Completely unexpectedly, the enzyme ceramidase emerges as a new target structure for the therapy of SARS-CoV-2 infections, researchers report. Completely unexpectedly, the enzyme ceramidase emerges as ...

The virus that causes COVID-19 has the ability to alter the genome structure of cells, which may play a role in long COVID-19, according to new findings from researchers at UTHealth Houston. Some ...

In a recent preprint* research paper uploaded to the Research Square server, researchers investigated the pathophysiology of post-COVID-19 cognitive defects. They used serum biomarkers and ...

In a recent study published in the journal Brain, Behavior, & Immunity - Health, researchers conducted a prospective population survey, functional brain imaging, and a cognitive task performance test ...

AUSTIN (KXAN) — Scientists are working to understand the long-term effects of COVID-19, including on those who didn’t have serious infections. Research, including at the University of Texas at Austin, ...

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at ...